1.Hee-Yong Kim, Bill X. Huang and Arthur A. Spector. Phosphatidylserine in the Brain: Metabolism and Function. Journal List, HHS Author Manuscripts, PMC4258547.

2.J.Hellhammer et.al. Effects of Soy Lecithin Phosphatidic Acid and Phosphatidylserine Complex (PAS) on the Endocrine and Psychological Responses to Mental Stress. Pages 119-126, Published online: 07 Jul 2009

3.M Maggioni et.all. Effects of phosphatidylserine therapy in geriatric patients with depressive disorders. Acta Psychiatr Scand. 1990 Mar;81(3):265-70.

4.Jorge S Valadas, Giovanni Esposito, Dirk Vandekerkhove, Katarzyna Miskiewicz, LiesbethDeaulmerie, Susanna Raitano, Philip Seibler, Christine Klein, PatrikVerstreken. ER Lipid Defects in Neuropeptidergic Neurons Impair Sleep Patterns in Parkinson’s Disease. 2018Jun27;98(6):1155-1169.e6. doi: 10.1016/j.neuron.2018.05.022. Epub 2018 Jun 7.

5.KusumSinha et. all. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sciences Volume 71, Issue 6, 28 June 2002, Pages 655-665

6.Yasushi Saito et.all. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).https://www.atherosclerosis-journal.com/article/S0021-9150(08)00394-8/fulltext.Accessed April6, 2021

7.Mitsuhiro Yokoyama at.all, Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.Lancet. 2007 Mar 31;369(9567):1090-8. doi: 10.1016/S0140-6736(07)60527-3.

8.M Ando ,T Sanaka, H Nihei. Eicosapentanoic acid reduces plasma levels of remnant lipoproteins and prevents in vivo peroxidation of LDL in dialysis patients. J Am Soc Nephrol. 1999 Oct;10(10):2177-84.

9.N Nakamura, T Hamazaki, M Ohta, K Okuda, M Urakaze, S Sawazaki, K Yamazaki, A Satoh, R Temaru, Y Ishikura, M Takata, M Kishida, M Kobayashi. Joint effects of HMG-CoA reductase inhibitors and eicosapentaenoic acids on serum lipid profile and plasma fatty acid concentrations in patients with hyperlipidemia. Int J Clin Lab Res . 1999;29(1):22-5. doi: 10.1007/s005990050057

* Мається на увазі метафоричне та стилістичне порівняння застосування комплексу Інтеларія/Intelaria для сприяння нормальної функції мозку, завдяки вмісту докозагексаєнової кислоти.
**позитивний ефект може бути отримано при щоденному вживанні 250 мг ДГК
***позитивний ефект може бути отримано при щоденному вживанні 250 мг ДГК+ЕПК